查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198592

遠程超聲系統市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Teleultrasound System Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，遠程超聲診斷系統市場預計將以 6% 的複合年增長率增長。

主要亮點

  • COVID-19 的出現對市場的增長產生了重大影響。 在大流行初期，視頻問診開始流行，以減少就診次數並避免感染風險。 由於其在疾病診斷中的先進應用，望遠鏡超聲 (TUS) 在此期間獲得了普及。
  • 根據 2022 年 6 月發表在《醫學與生物學超聲雜誌》上的一篇論文，超聲在急診分診中發揮著重要作用，有助於降低孕婦、兒童等特定患者群體感染 COVID-19 的風險，和行動不便的患者。19 在識別肺炎方面提供了明顯的優勢。 因此，TUS 獲得了需求，並且 TUS 的應用隨著時間的推移而增加。
  • 由於 TUS 是一種先進技術，其診斷準確性和圖像質量可與常規超聲相媲美，根據上述消息來源，在 COVID-19 期間需要提高遠程醫療 (TH) 能力。這被視為一個問題當然。 因此，大流行對所研究的市場產生了相當積極的影響，預計在預測期內將保持其強大的主導地位。
  • 在預測期內，先進診斷技術的引入、目標疾病患病率的增加以及老年人口的增加等因素預計將促進市場增長。
  • 研究目標市場的增長歸因於癌症和心血管疾病等目標疾病的患病率上升。 例如，根據英國心臟基金會（BHF）2022年8月發布的《英國概況》，全國約有760萬人患有心臟和循環系統疾病，男性約400萬，女性約400萬。約360萬人們。 心臟和循環系統疾病的患病率非常高，推動了對新診斷方案的需求。 由於近年來遠程醫療的盛行，疾病的爆發有望為在研市場帶來新的機遇，加速市場擴張。
  • 此外，技術先進產品的興起和主要參與者的其他戰略活動也在推動所研究的市場。 例如，2022年3月，GE Healthcare向Pulsenmore Ltd戰略投資5000萬美元，通過Pulsenmore與智能手機對接的手持式TUS設備進軍家庭護理領域，讓女性在家中自主掃描超聲波，獲得及時的醫療臨床反饋。專業人員。 預計此類新興市場的發展將在預測期內推動市場增長。
  • 但是，缺乏熟練的專業人員以及對數據安全和隱私的擔憂可能會阻礙預測期內的市場增長。

遠程超聲系統市場趨勢

實時遠程超聲診斷細分市場有望穩步增長

  • 實時超聲系統是實用系統，因為它們支持同步（實時）遠程超聲檢查。 因此，實時 TUS 系統有望得到積極擴展。
  • 如 2021 年 8 月發表在《超聲心動圖雜誌》上的一篇論文所示，可以共享屏幕並與遠程醫生實時交流的新型超聲診斷設備的出現最近獲得了需求。 它為無法執行常規超聲的醫生提供了一個獨特的機會，可以通過使用實時 TUS 在實時諮詢中提供專家建議。
  • 此外，如上述來源所述，研究人員發現使用支持 TUS 的新型便攜式平板電腦超聲系統時超聲心動圖結果有所改善。 由於此類情況，對實時 TUS 的需求正在增加，預計未來會進一步增長。
  • 此外，遠程實時監控系統的開發可以為急救醫務人員提供院前急救超聲診斷支持。 例如，飛利浦超聲系統 EPIQ 和 Affiniti Collaboration Live 使臨床醫生能夠與同事實時協作，隨時隨地完成圖像採集和診斷。 這些先進的技術和功能有望推動該細分市場的增長。 因此，上述因素表明實時 TUS 的採用越來越多，預計將在預測期內推動細分市場的增長。

北美佔據了很大的市場份額，預計在預測期內也會如此

  • 北美在所研究的市場中佔有很大份額，預計在預測期內仍將是其據點。 這背後的主要因素是癌症和心髒病等慢性病的增加、老年人口的增加以及具有先進技術的產品的普及。
  • 作為遠程醫療領域，TUS 有可能解決缺乏高質量超聲檢查（包括乳腺超聲篩查）醫療資源的問題。 對於沒有超聲診斷經驗的醫生進行癌症篩查也很有用。 市場增長的主要驅動力是北美國家不斷增加的癌症發病率。 例如，根據美國癌症協會 (ACS) 發布的《2022 年癌症事實與數據》，2022 年美國將可能診斷出約 190 萬例新癌症病例。
  • 根據國家癌症研究所 (NCI) 2022 年更新，乳腺癌是最常見的癌症。 根據上述來源，估計 2022 年美國將有 290,560 例乳腺癌新病例。 前列腺癌和肺癌是下一個最常見的癌症。 由於這種癌症負擔，預計與癌症相關的篩查將會增加。 預計這將進一步增加對 TUS 系統的需求，並在預測期內推動市場增長。
  • 此外，預計該地區多家醫院和診所採用 TUS 系統也將有助於市場增長。 例如，2022 年 5 月，Jefferson Radiology 推出了用於超聲預約的高級遠程醫療軟件。 Collaboration Live 是 Philips(TM) 的 TUS 軟件，它使放射科醫生能夠虛擬地實時連接患者，從而顯著改善患者的就診。 因此，預計此類案例將有助於該地區的市場增長。
  • 因此，預計北美在癌症篩查中採用 TUS 將在預測期內推動市場增長。

遠程超聲系統市場競爭對手分析

遠程超聲系統市場競爭激烈，由多家大型企業組成。 從市場份額的角度來看，一些主要參與者主導著市場。 目前主導市場的公司包括 Koninklijke Philips N.V、Remote Medical Technologies, LLC、Robo Medical、AdEchoTech、T-MedRobotics 和 Pulsenmore Ltd。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 先進診斷技術簡介
    • 目標疾病的流行率增加
    • 老年人口增加
  • 市場製約因素
    • 缺乏熟練的專業人員
    • 缺乏數據安全和隱私問題
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按類型
    • 常規遠程超聲診斷
    • 實時遠程診斷成像
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Koninklijke Philips N.V.
    • Remote Medical Technologies, LLC
    • Robo Medical
    • AdEchoTech
    • T-MedRobotics
    • Analogic Corporation
    • AMD Global Telemedicine
    • ONRAD, Inc.
    • Ram Soft, Inc.
    • Medica Group PLC.
    • Pulsenmore Ltd.
    • BMV Medtech Group Co., Ltd.

第7章 市場機會與今後動向

簡介目錄
Product Code: 68873

The teleultrasound system market is expected to register a CAGR of 6% during the forecast period.

Key Highlights

  • The emergence of COVID-19 significantly impacted the market growth. During the initial phase of the pandemic, video consultations became more popular to reduce the number of hospital visits and avoid the risk of infection. Teleultrasound (TUS) gained traction during that time due to its advanced application for disease diagnosis.
  • As per an article published in June 2022 in the Journal of Ultrasound in Medicine and Biology, ultrasound played a crucial role in emergency triage and provided clear benefits in identifying COVID-19 pneumonia for specific patient populations, including expectant mothers, children, and immobile patients. Hence, the TUS gained demand, and the application of TUS increased over time.
  • As per the source above, TUS was incorporated as an obvious step to improve the capabilities of telehealth (TH) during the COVID-19 period, as TUS is an advanced technology with diagnostic precision and image quality comparable to regular ultrasound exams. Hence, the pandemic had a considerably positive impact on the studied market and is expected to continue its strong hold over the forecast period.
  • Factors such as the introduction of technologically advanced diagnostics, increasing prevalence of target diseases, and growing geriatric population base are expected to contribute to the market growth over the forecast period.
  • The growth of the studied market is attributed to the increasing prevalence of target diseases such as cancer and cardiovascular diseases. For instance, according to the "UK Factsheet" published by the British Heart Foundation (BHF) in August 2022, there are around 7.6 million people in the country who suffer from heart and circulatory disorders, with almost 4 million men and 3.6 million women. Patients with heart and circulatory diseases, which are extremely common, drive demand for new diagnostic options. As telehealth has grown in popularity in recent years, it is projected that the incidence of diseases will open up new opportunities for the market under study and accelerate market expansion.
  • Moreover, the increasing availability of technologically advanced products and other strategic activities by the major players is also boosting the market studied. For instance, in March 2022, GE Healthcare strategically invested USD 50 million in Pulsenmore Ltd and entered the homecare segment through Pulsenmore's handheld TUS device that docks with a smartphone, allowing women to perform ultrasound self-scans at home and receive fast clinical feedback from healthcare professionals. Such developments are anticipated to drive market growth during the forecast period.
  • However, the lack of skilled professionals and data security and privacy concerns are likely to hamper the market growth over the forecast period.

Teleultrasound System Market Trends

Real-Time Teleultrasound​ Segment is Expected to Witness a Healthy Growth

  • Real-time ultrasound systems are practical because they enable synchronous (real-time) remote ultrasonographic tests. Thus, it is anticipated that the real-time TUS system will expand positively.
  • As per an article published in August 2021 in the Journal of Echocardiography, the emergence of a novel ultrasound device that enables real-time screen sharing and telecommunication with remote doctors has gained demand recently. That provides a unique opportunity for doctors unable to perform the traditional ultrasound to provide expert advice during a real-time consultation by using real-time TUS.
  • In addition, as per the source above, when the study researchers used a novel tablet-based hand-held ultrasound device that enables TUS, it provided improved echocardiography results. Thus, owing to such instances, the real-time TUS is gaining demand and is anticipated to fuel segmental growth.
  • Furthermore, prehospital emergency ultrasonography support for emergency medicine practitioners may be possible with the development of remote real-time supervision. For instance, Philips Ultrasound Systems EPIQ and Affiniti Collaboration Live allow clinicians to collaborate in real-time with colleagues to complete image acquisition and diagnosis regardless of location. These advanced technology and features are expected to drive segmental growth. Therefore, the above factors show an increase in the adoption of real-time TUS, and it is expected to fuel the segment growth over the forecast period.

North America Holds a Significant Share in the Market and Expected to do Same in the Forecast Period

  • North America holds a major market share in the studied market and is anticipated to maintain its stronghold during the forecast period. The growth is majorly attributed to the increase in chronic diseases such as cancer and cardiology, the geriatric population, and the availability of technically advanced products.
  • As a branch of telemedicine, TUS can potentially solve the problem of insufficient medical resources for high-quality ultrasound examinations, including breast ultrasound screening. It can also help physicians without ultrasound experience to perform cancer screenings. The major factor behind the market growth is the increasing burden of cancer in North American countries. For instance, according to the Cancer Facts and Figures 2022 published by the American Cancer Society (ACS), nearly 1.9 million new cancer cases will likely be diagnosed in the United States in 2022.
  • In addition, according to the National Cancer Institute (NCI) 2022 update, breast cancer is the most common cancer. As per the source above, it is estimated that there will be 290,560 new breast cancer cases in the United States in 2022. Prostate cancer and lung cancer are the next most frequent cancers in the country. This burden of cancer is anticipated to increase the screenings related to cancer. This is further expected to increase demand for TUS systems, thereby driving the market growth over the forecast period.
  • Furthermore, the adoption of TUS systems by various hospitals and clinics in the region is expected to contribute to market growth. For instance, in May 2022, Jefferson Radiology implemented advanced telemedicine software for its diagnostic ultrasound appointments. Collaboration Live, a TUS software by Philips™, will dramatically improve patient access by enabling radiologists to connect with patients virtually and in real-time. Thus, such instances are expected to contribute to regional market growth.
  • Hence, the studied market is anticipated to witness growth owing to the TUS adoption in North America's cancer screening during the forecast period.

Teleultrasound System Market Competitor Analysis

The teleultrasound system market is competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some companies currently dominating the market are Koninklijke Philips N.V, Remote Medical Technologies, LLC, Robo Medical, AdEchoTech, T-MedRobotics, and Pulsenmore Ltd., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Introduction of Technologically Advanced Diagnostics
    • 4.2.2 Increasing Prevalence of Target Diseases
    • 4.2.3 Growing Base of Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 Lack of Data Security and Privacy Concerns
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Traditional teleultrasound
    • 5.1.2 Real-Time Teleultrasound
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips N.V.
    • 6.1.2 Remote Medical Technologies, LLC
    • 6.1.3 Robo Medical
    • 6.1.4 AdEchoTech
    • 6.1.5 T-MedRobotics
    • 6.1.6 Analogic Corporation
    • 6.1.7 AMD Global Telemedicine
    • 6.1.8 ONRAD, Inc.
    • 6.1.9 Ram Soft, Inc.
    • 6.1.10 Medica Group PLC.
    • 6.1.11 Pulsenmore Ltd.
    • 6.1.12 BMV Medtech Group Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS